National and Kapodistrian University of Athens
Μελέτη του ρόλου του διαλυτού και διαμεμβρανικού TNF κατά την παθολογία του ΚΝΣ
Abstract
dc:descriptionTNF is a member of a large family of cytokines and has multiple roles in the CNS. Regulated TNF production is necessary for successful host defense responses against infection and for tissue repair mechanisms. On the other hand, deregulation of TNF production and molecular signaling leads to chronic inflammation and immune activation, which can lead to autoimmunity. Increased TNF levels have been associated with inflammatory autoimmune diseases, including neurodegenerative CNS disorders such as multiple sclerosis (MS). However, while TNF inhibitors are blockbuster drugs for chronic immune diseases in the periphery, such as rheumatoid arthritis, they exacerbate disease in MS patients, induce de novo demyelination in patients treated for other diseases, and even cause MS. These clinical data clearly show that TNF has overall beneficial effects in the CNS. In experimental models for MS, TNF receptor 1 (TNFR1) mediates the detrimental pro- inflammatory effects of soluble TNF (solTNF), whereas TNFR2 and transmembrane TNF (tmTNF) are essential for beneficial effects, mainly in myelin maintenance and repair. This mechanistic framework supports the use of novel selective inhibitors of solTNF and/or TNFR1, or TNFR2 agonists, for safer therapy of chronic inflammatory diseases including those of the CNS. A potential obstacle to such an approach is substantial evidence that TNF has neuroprotective effects against a wide variety of oxidative and excitotoxic stimuli when used to pretreat cultured neurons, and that protection involves both TNFR1 and TNFR2. However, the relevance of these effects for CNS protection in vivo have yet to be proven and is this subject of this thesis. In a separate line of investigation, previous studies in our lab show that, similar to TNF, conditioned medium from MSC has neuroprotective effects against glutamate excitotoxicity when used to pretreat cultured neurons. MSC provide therapeutic effects in experimental CNS disease models and therefore show promise as cell-based therapies for humans. However, their modes of action, and whether TNF is secreted and involved in their neuroprotection, need to be elucidated. To address the questions described above, we used a genetic approach, combining mice with conventionally and conditionally targeted genes for TNF and its receptors, with an in vitro of glutamate excitotoxicity and in vivo models for multiple sclerosis. Glutamate, and specifically NMDA excitotoxicity, was used because it is directly relevant for neuronal death in a wide variety of neurodegenerative disorders including MS. The NMDA, AMPA and kainate receptors belong to the family of ionotropic glutamate receptors and bind glutamate, which is the major excitatory neurotransmitter in the mammalian CNS. Under certain conditions, dysregulated glutamate function can lead to pathology. High levels of glutamate are toxic for neurons and induce so-called excitotoxic death resulting from increased calcium influx into the cell via the NMDA receptors. First the neuroprotective function of TNF against NMDA-mediated excitotoxicity in vitro was verified. Specifically, pre-incubation of mixed astrocyte-neuron co-cultures with exogenous solTNF protected neurons against NMDA-induced excitotoxicity. Similar neuroprotection was observed after pre-incubation of the cultures with conditioned medium from MSC (MSC CM). Indeed, MSC CM was found to contain measurable TNF bioactivity, and pre-treatment of MSC CM with the TNF inhibitor etanercept reduced its ability to protect neurons, suggesting that MSC-mediated neuroprotection against glutamate excitotoxicity involves, in part, the production of TNF. Subsequently, the cellular and molecular mechanisms by which pre-treatment of cortical neurons with TNF leads to neuroprotection against NMDA-induced excitotoxicity in vitro, were investigated. For this, astrocytes and neurons were isolated from the cortex of wild-type mice or mice deficient in TNF or TNF receptors, and different combinations of wildtype and knockout cells were used to generate astrocyte- neuron co-cultures. It was found that preconditioning of cultures with exogenous solTNF activates astrocytes through TNFR1 to produce tmTNF, which in turn induces neuroprotection mainly via neuronal TNFR2. Specifically, solTNF protects cortical neurons against NMDA-induced excitotoxicity. The in vivo relevance of TNF neuroprotection to MS, was investigated by cell-specific gene targeting of TNFR1 and TNFR2 specifically in excitatory glutamatergic neurons in mice and study of their effect in two experimental MS models, experimental autoimmune encephalomyelitis (EAE) and cuprizone demyelination (CPZ). In contrast to the in vitro results, neuronal TNFR1 promoted disease onset in EAE and CPZ, via activation of its downstream mediator IKKβ. In addition, neuronal TNFR1 increased oligodendrocyte loss and axon damage in CPZ. On the other hand, neuronal TNFR2 did not alter the onset or progression of disease in either of the experimental MS models studied. These results show that the neuroprotective effects of TNF observed in vitro do not protect mice against the development of clinical symptoms or neuropathology typical of MS, in the EAE or CPZ models, and provide full support for the development of novel therapeutic strategies aimed at selectively inhibiting solTNF and/or TNFR1 for the treatment of CNS inflammatory diseases such as MS.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papazian, Irini
- Παπαζιάν, Ειρήνη
Subjects
dc:subject × 19- TNF υποδοχείς
- TNF
- Νευροεκφυλισμός
- Νευροπροστασία
- Σκλήρυνση κατά πλάκας
- Γλουταμινικοί υποδοχείς
- Απομυελίνωση απο κουπριζόνη
- Πειραματική αυτοάνοση εγκεφαλομυελίτιδα
- TNF receptors
- Neurodegeneration
- Neuroprotection
- Multiple sclerosis
- Glutamate receptors
- Cuprizone model
- Experimental autoimmune encephalomyelitis
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45595